How Many Lymph Nodes are Enough in Paratesticular Rhabdomyosarcoma?
Author / Expert
Katelyn A. Spencer, Brittany Levy, Will Cranford, Christopher J. McLouth, Haley Copeland, Jonathan C. Routh, David A. Rodeberg, Amanda F. Buchanan
Topic overview
Treatment strategies for paratesticular rhabdomyosarcoma (PT RMS) are based on stage, which requires accurate lymph node (LN) evaluation. Previous methodology for determining quantity of LN for negative nodal status is based on LN positivity rates, without accounting for the relationship between LNs or amongst patients. This study aims to quantify the chance of missing involved LNs based on LN yield (LNY) using a previously established methodology in comparison to current recommendations.
Comments